![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page1133.jpg)
39
Conclusion dose effect BT (II)
Future Perspective EMBRACE II + clinical endpoint specific
prospective protocol:
planning aims and limits for miminum prescribed dose
”soft constraints” and ”hard constraints”
taking into account multiple parameters:
Target dose CTV
HR,
(CTV
IR
GTV
res
)
Target volume CTV
HR,
(CTV
IR
GTV
res
)
Overall treatment time <50 days
OARs D2cm
3
and dose points (vagina, rectum)